283 related articles for article (PubMed ID: 26318434)
1. The role of P2X7 receptors in tissue fibrosis: a brief review.
Gentile D; Natale M; Lazzerini PE; Capecchi PL; Laghi-Pasini F
Purinergic Signal; 2015 Dec; 11(4):435-40. PubMed ID: 26318434
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the P2X7 purinergic receptor in inflammation: an update of antagonists series since 2009 and their promising therapeutic potential.
Baudelet D; Lipka E; Millet R; Ghinet A
Curr Med Chem; 2015; 22(6):713-29. PubMed ID: 25515510
[TBL] [Abstract][Full Text] [Related]
3. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.
Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V
Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059
[TBL] [Abstract][Full Text] [Related]
4. P2X7 Receptor as a Therapeutic Target.
De Marchi E; Orioli E; Dal Ben D; Adinolfi E
Adv Protein Chem Struct Biol; 2016; 104():39-79. PubMed ID: 27038372
[TBL] [Abstract][Full Text] [Related]
5. [Effect of P2X7 receptor on inflammatory diseases and its mechanism].
Xu H; Liang SD
Sheng Li Xue Bao; 2013 Apr; 65(2):244-52. PubMed ID: 23598883
[TBL] [Abstract][Full Text] [Related]
6. [Advance in the research on P2X7 and inflammatory respiratory diseases].
Cao SH; Yuan SP; Hou Q
Yao Xue Xue Bao; 2013 Aug; 48(8):1183-8. PubMed ID: 24187823
[TBL] [Abstract][Full Text] [Related]
7. P2X7 receptor in cardiovascular disease: The heart side.
Guerra Martinez C
Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):513-526. PubMed ID: 30834550
[TBL] [Abstract][Full Text] [Related]
8. Adipocyte P2X7 receptors expression: a role in modulating inflammatory response in subjects with metabolic syndrome?
Madec S; Rossi C; Chiarugi M; Santini E; Salvati A; Ferrannini E; Solini A
Atherosclerosis; 2011 Dec; 219(2):552-8. PubMed ID: 21978920
[TBL] [Abstract][Full Text] [Related]
9. Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7.
Hattori F; Ohshima Y; Seki S; Tsukimoto M; Sato M; Takenouchi T; Suzuki A; Takai E; Kitani H; Harada H; Kojima S
Eur J Pharmacol; 2012 Nov; 695(1-3):20-6. PubMed ID: 22981895
[TBL] [Abstract][Full Text] [Related]
10. Purinergic receptors: new targets for the treatment of gout and fibrosis.
Gicquel T; Le Daré B; Boichot E; Lagente V
Fundam Clin Pharmacol; 2017 Apr; 31(2):136-146. PubMed ID: 27885718
[TBL] [Abstract][Full Text] [Related]
11. P2X7 receptor antagonists: a patent review (2010-2015).
Park JH; Kim YC
Expert Opin Ther Pat; 2017 Mar; 27(3):257-267. PubMed ID: 27724045
[TBL] [Abstract][Full Text] [Related]
12. The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease.
Bartlett R; Stokes L; Sluyter R
Pharmacol Rev; 2014 Jul; 66(3):638-75. PubMed ID: 24928329
[TBL] [Abstract][Full Text] [Related]
13. The role of P2X7 receptor in infectious inflammatory diseases and the influence of ectonucleotidases.
Morandini AC; Savio LE; Coutinho-Silva R
Biomed J; 2014; 37(4):169-77. PubMed ID: 25116711
[TBL] [Abstract][Full Text] [Related]
14. The evolution of P2X7 antagonists with a focus on CNS indications.
Rech JC; Bhattacharya A; Letavic MA; Savall BM
Bioorg Med Chem Lett; 2016 Aug; 26(16):3838-45. PubMed ID: 27426304
[TBL] [Abstract][Full Text] [Related]
15. The P2X7 purinergic receptor: An emerging therapeutic target in cardiovascular diseases.
Chen Z; He L; Li L; Chen L
Clin Chim Acta; 2018 Apr; 479():196-207. PubMed ID: 29366837
[TBL] [Abstract][Full Text] [Related]
16. P2X7 blockade attenuates mouse liver fibrosis.
Huang C; Yu W; Cui H; Wang Y; Zhang L; Han F; Huang T
Mol Med Rep; 2014 Jan; 9(1):57-62. PubMed ID: 24247209
[TBL] [Abstract][Full Text] [Related]
17. P2X7 receptor signaling in the pathogenesis of smoke-induced lung inflammation and emphysema.
Lucattelli M; Cicko S; Müller T; Lommatzsch M; De Cunto G; Cardini S; Sundas W; Grimm M; Zeiser R; Dürk T; Zissel G; Sorichter S; Ferrari D; Di Virgilio F; Virchow JC; Lungarella G; Idzko M
Am J Respir Cell Mol Biol; 2011 Mar; 44(3):423-9. PubMed ID: 20508069
[TBL] [Abstract][Full Text] [Related]
18. Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states.
Donnelly-Roberts DL; Jarvis MF
Br J Pharmacol; 2007 Jul; 151(5):571-9. PubMed ID: 17471177
[TBL] [Abstract][Full Text] [Related]
19. P2X7 receptor antagonism in the treatment of cancers.
Roger S; Pelegrin P
Expert Opin Investig Drugs; 2011 Jul; 20(7):875-80. PubMed ID: 21619470
[TBL] [Abstract][Full Text] [Related]
20. Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice.
Engel T; Gomez-Villafuertes R; Tanaka K; Mesuret G; Sanz-Rodriguez A; Garcia-Huerta P; Miras-Portugal MT; Henshall DC; Diaz-Hernandez M
FASEB J; 2012 Apr; 26(4):1616-28. PubMed ID: 22198387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
